Henryk Barthel
Overview
Explore the profile of Henryk Barthel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
5817
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rullmann M, Henssen D, Melasch J, Scherlach C, Saur D, Schroeter M, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 39937274
Purpose: Heterogeneity in clinical phenotypes has led to the description of different phenotypes of Alzheimer's disease (AD). Besides the most frequent amnestic variant of AD (aAD), patients presenting with language...
2.
Bauer T, Brendel M, Zaganjori M, Bernhardt A, Bernhardt A, Jack A, et al.
Neuroimage
. 2025 Jan;
306():121001.
PMID: 39798829
Aim: Standardized evaluation of [F]PI-2620 tau-PET scans in 4R-tauopathies represents an unmet need in clinical practice. This study aims to investigate the effectiveness of visual evaluation of [F]PI-2620 images for...
3.
Slemann L, Gnorich J, Hummel S, Bartos L, Klaus C, Kling A, et al.
Acta Neuropathol
. 2024 Nov;
148(1):70.
PMID: 39580770
Tau PET has attracted increasing interest as an imaging biomarker for 4-repeat (4R)-tauopathy progressive supranuclear palsy (PSP). However, the translation of in vitro 4R-tau binding to in vivo tau PET...
4.
Arbizu J, Morbelli S, Minoshima S, Barthel H, Kuo P, Van Weehaeghe D, et al.
J Nucl Med
. 2024 Oct;
PMID: 39419552
PREAMBLEThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine....
5.
Dilcher R, Wall S, Gross M, Katzdobler S, Wagemann O, Palleis C, et al.
Alzheimers Dement
. 2024 Sep;
20(10):6896-6909.
PMID: 39263969
Introduction: Recent advances in biomarker research have improved the diagnosis and monitoring of Alzheimer's disease (AD), but in vivo biomarker-based workflows to assess 4R-tauopathy (4RT) patients are currently missing. We...
6.
Buchert R, Huppertz H, Wegner F, Berding G, Brendel M, Apostolova I, et al.
J Neurol Neurosurg Psychiatry
. 2024 Aug;
PMID: 39107038
Background: Diagnostic criteria for progressive supranuclear palsy (PSP) include midbrain atrophy in MRI and hypometabolism in [F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) as supportive features. Due to limited data regarding their...
7.
Gnorich J, Koehler M, Wind-Mark K, Klaus C, Zatcepin A, Palumbo G, et al.
Neuroimage
. 2024 Jul;
297:120748.
PMID: 39069223
Aim: β-amyloid (Aβ) small animal PET facilitates quantification of fibrillar amyloidosis in Alzheimer's disease (AD) mouse models. Thus, the methodology is receiving growing interest as a monitoring tool in preclinical...
8.
Barba L, Abu-Rumeileh S, Barthel H, Massa F, Foschi M, Bellomo G, et al.
Brain
. 2024 Jul;
147(10):3325-3343.
PMID: 38991041
Concomitant Alzheimer's disease (AD) pathology is a frequent event in the context of Lewy body disease (LBD), occurring in approximately half of all cases. Evidence shows that LBD patients with...
9.
Brendel M, Guedj E, Yakushev I, Morbelli S, Hoglinger G, Tolboom N, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jun;
51(12):3496-3500.
PMID: 38907856
No abstract available.
10.
Roemer S, Brendel M, Gnorich J, Malpetti M, Zaganjori M, Quattrone A, et al.
Brain
. 2024 Jun;
147(7):2428-2439.
PMID: 38842726
Four-repeat (4R) tauopathies are neurodegenerative diseases characterized by cerebral accumulation of 4R tau pathology. The most prominent 4R tauopathies are progressive supranuclear palsy (PSP) and corticobasal degeneration characterized by subcortical...